[VE-cadherin takes a walk on the wild side].
Gavard
Julie
J
Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, DHHS, Bethesda, Maryland 20892-4340, USA. jgavard@mail.nih.gov
Gutkind
J Silvio
JS
D000818:Animals; D015703:Antigens, CD / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D015820:Cadherins / Q000737:chemistry / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D002199:Capillary Permeability / Q000502:physiology; D022163:Clathrin-Coated Vesicles / Q000502:physiology; D004705:Endocytosis; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D008954:Models, Biological; D018919:Neovascularization, Physiologic / Q000502:physiology*; D010766:Phosphorylation; D010768:Phosphoserine / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000502:physiology; D054462:p21-Activated Kinases; D000099152:Cadherin 5
D015703:Antigens, CD; D015820:Cadherins; D010768:Phosphoserine; D017346:Protein Serine-Threonine Kinases; D042461:Vascular Endothelial Growth Factor A; D040301:Vascular Endothelial Growth Factor Receptor-2; D054462:p21-Activated Kinases; D000099152:Cadherin 5